ArabFinance: GlaxoSmithKline's (GSK Egypt) (BIOC) ordinary general assembly approved on May 26th the annual cash dividends of EGP 0.50 per share for 2020, according to the company's statement released on May 27th.
GSK-Egypt has intended to stabilize its operation in Egypt
GSK Egypt stated the exit from the Egyptian market came in line with the parent companys strategy to shrink its investment in emerging markets.
The listed company reported a 51% Year on Year leap in its consolidated net profit in the first nine months of 2020, recording EGP 101.39 million.
GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.
Copyright 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).